Application 206544
- Type
- NDA
- Sponsor
- DAIICHI SANKYO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MORPHABOND ER | MORPHINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | 15MG | Yes | No |
| 002 | MORPHABOND ER | MORPHINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | 30MG | Yes | No |
| 003 | MORPHABOND ER | MORPHINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | 60MG | Yes | No |
| 004 | MORPHABOND ER | MORPHINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | 100MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N206544-001 | MORPHABOND ER | MORPHINE SULFATE | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | |
| N206544-002 | MORPHABOND ER | MORPHINE SULFATE | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | |
| N206544-003 | MORPHABOND ER | MORPHINE SULFATE | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | |
| N206544-004 | MORPHABOND ER | MORPHINE SULFATE | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | |
| N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | |
| N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | |
| N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | |
| N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | |
| N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | |
| N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | |
| N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206544-001 | MORPHABOND ER | 15MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206544-002 | MORPHABOND ER | 30MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206544-003 | MORPHABOND ER | 60MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206544-004 | MORPHABOND ER | 100MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2015-10-02 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-001 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-001 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-002 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-002 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-003 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-003 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-004 | 10314788 | 2028-08-12 | Drug product | 2019-07-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206544-004 | 7955619 | 2028-08-12 | Drug product | 2016-03-24 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | American Health Packaging | 5422cdac-8073-41fc-8665-ffe9797f5c02 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | 1d181906-f3ec-4222-1883-e61577a3122e | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate Extended Release | MORPHINE SULFATE | Bryant Ranch Prepack | 2dd52157-3121-41ed-abc2-99b269531e56 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| MORPHINE SULFATE | MORPHINE SULFATE | Bryant Ranch Prepack | d1b0b4ac-69d9-44bf-b7a3-229bd89b9fd6 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate Extended Release | MORPHINE SULFATE | Bryant Ranch Prepack | c94d9da6-7a12-44ee-a38f-3323ee27842c | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate ER | MORPHINE SULFATE | Bryant Ranch Prepack | 872ceecb-1f14-7a43-7451-e4650a01fbd9 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | cc3b491c-a206-3027-54f0-f87c0dd40a7f | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine sulfate | MORPHINE SULFATE | Sun Pharmaceutical Industries, Inc. | 736c9b80-682c-4cda-bf18-61b18de0bd39 | 2026-03-15 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine sulfate | MORPHINE SULFATE | Actavis Pharma, Inc. | 2da87bfa-11fd-43e3-8fef-d16ebeb15680 | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| MITIGO | MORPHINE SULFATE | Piramal Critical Care, Inc. | 728f3d83-9a63-0c1f-e053-2a91aa0ac7db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Cranbury Pharmaceuticals, LLC | d8598654-94ad-4cfb-81d2-9b68e013a428 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 07993f6c-146b-4728-a2da-6e93089f78ff | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | American Health Packaging | 66a3f607-7f48-490f-84dd-b74dd1ee39e5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | ca359246-4674-4b32-b8b2-673d32b7112f | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | 3c847554-3b4b-4d24-a145-2ef7e9b83699 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 3a89d0ca-4ff8-4bdc-8ea8-9ad591ce7226 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | PAI Holdings, LLC dba PAI Pharma | 9405556c-20e0-4e47-b1b0-7872bcc6517e | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | be420e8b-bcb0-49b5-bb4d-1df8b9959809 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | ee8057d1-ed12-4e18-9efa-d83504abf612 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
| Duramorph | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | ebb18761-e5c4-4238-bb84-f9549f500210 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | MORPHINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65597-301 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-301 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-301 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-301 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-302 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-302 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-302 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-302 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-303 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-303 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-303 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-303 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-304 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-304 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-304 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
| 65597-304 | MorphaBond | morphine sulfate | Daiichi Sankyo Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 60429 | SUPPL | 2019-10-09 |
| 60428 | SUPPL | 2019-10-09 |
| 60371 | SUPPL | 2019-10-08 |
| 57123 | SUPPL | 2019-02-04 |
| 57092 | SUPPL | 2019-01-02 |
| 55677 | SUPPL | 2018-10-01 |
| 55676 | SUPPL | 2018-10-01 |
| 55543 | SUPPL | 2018-09-21 |
| 55542 | SUPPL | 2018-09-21 |
| 54426 | SUPPL | 2018-06-04 |
| 54424 | SUPPL | 2018-06-04 |
| 48592 | SUPPL | 2017-05-31 |
| 46440 | SUPPL | 2016-12-21 |
| 46439 | SUPPL | 2016-12-21 |
| 46323 | SUPPL | 2016-12-20 |
| 46322 | SUPPL | 2016-12-20 |
| 46066 | ORIG | 2016-10-20 |
| 46065 | ORIG | 2016-10-20 |
| 45453 | SUPPL | 2016-10-03 |
| 10579 | SUPPL | 2016-04-22 |
| 44601 | ORIG | 2015-11-04 |
| 24128 | ORIG | 2015-10-16 |
| 40556 | ORIG | 2015-10-09 |
| 10578 | ORIG | 2015-10-09 |